Drug Shortage Report for TRISENOX

Last updated on 2018-07-30 History
Report ID 15753
Drug Identification Number 02407833
Brand name TRISENOX
Common or Proper name Arsenic Trioxide for Injection
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ARSENIC TRIOXIDE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 mg/10mL ampoule
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-09-08
Actual start date 2017-09-08
Estimated end date 2018-07-20
Actual end date 2018-07-24
Shortage status Resolved
Updated date 2018-07-30
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v35 2018-07-30 French Compare
v34 2018-07-30 English Compare
v33 2017-12-15 French Compare
v32 2017-12-15 English Compare
v31 2017-12-15 English Compare
v30 2017-10-20 French Compare
v29 2017-10-20 English Compare
v28 2017-09-09 English Compare
v27 2017-08-23 French Compare
v26 2017-08-23 English Compare
v25 2017-08-10 French Compare
v24 2017-08-10 English Compare
v23 2017-07-28 French Compare
v22 2017-07-28 English Compare
v21 2017-07-27 English Compare
v20 2017-07-27 French Compare
v19 2017-07-27 French Compare
v18 2017-07-27 English Compare
v17 2017-07-27 French Compare
v16 2017-07-27 French Compare

Showing 1 to 20 of 35